Temperature Controlled Packaging for Pharmaceutical Market Research Report - Forecast to 2027

Global Temperature-Controlled Packaging for Pharmaceutical Market: By Product (Insulated Shippers and Insulated Containers), By Type (Active Systems and Passive Systems), By Temperature Range (Up to 10°C, 10°C to 20°C and More than 20°C), By Payload Capacity (Up to 10 L, 10-20 L, 20-40 L, 40-150 L and More than 150 L), By Type of Use (Single Use and Reusable), By End-Use Industry (Pharmaceutical and Clinical Trial) and By Region - Forecast Till 2027

ID: MRFR/PNT/5724-CR | January 2019 | Region: Global | 170 pages

Please note that the assessment period of report has been updated from (2018-2023) to 2020-2027. Cordially fill the sample form for updated data.

Market Snapshot


Global temperature-controlled packaging for pharmaceutical market is set to increase at 9.48% CAGR between 2018 and 2023. Investment in pharmaceutical packaging has spiraled upwards, signaling towards a favorable status for the market during the projected future. Growing demand for effective packaging solutions in the pharmaceutical industry is primarily driving the market’s growth. In addition, players are likely to find tremendous opportunities in emerging markets over the next several years.


Synopsis


This MRFR report offers a detailed analysis of the global temperature-controlled packaging for pharmaceutical market. It also includes a five-year (2018-2023) revenue projection. The report covers historical growth, industry trends and opportunities, market restraints and growth drivers. Further a descriptive segmental study of the market based on different temperature-controlled packaging products is also available in the report.


Report Coverage


Historical market trends, market dynamics, forecast, market value by region as well as by segmentation, country-level analysis for each market segment, key player’s market share analysis and market factor analysis which covers supply chain and Porter’s five forces analysis of the market.


Companies Covered


Envirotainer AB, Cold Chain Technologies, Sofrigam, Pelican Bio Thermal, Sonoco ThermoSafe, Softbox Systems Limited, va-Q-tec AG, Storopack Hans Reichenecker GmbH, DHL International GmbH, DB Schenker, United Parcel Service of America, Inc. (UPS), and KUEHNE + NAGEL INC.


Research Methodology


Market Research Future (MRFR) employs a multi-layered statistical solution for the analysis of critical market elements to garner highly accurate insights. The advanced data triangulation technique aids in conducting extensive qualitative and quantitative analysis of macroeconomic indicators and governing factors of market such as historical trends, key market dynamics, consumer landscape, possible disruptions, and growth opportunities. Primary and secondary research processes ensure the authenticity and objectivity of the research findings. Primary research process aids in collection of data by conducting one-on-one interviews with key opinion holders across the value chain and undertaking detailed surveys. Secondary research module is utilized for verifying the collected data through inputs from existing industry documentations such as whitepapers, paid databases, annual reports, SEC filings and others. In addition to this, top-down and bottom-up approaches are utilized for optimum evaluation of research findings. 


Other Description



  • Market Denomination- USD Mn

  • Base Year- 2017

  • Forecast Period- from 2018 to 2023


For the scope of the research, MRFR’s report offers a comprehensive segmental analysis of the global market for temperature-controlled packaging for pharmaceutical


By Product



  • Insulated shippers

  • Insulated containers


By Type



  • Active systems

  • Passive systems


By Temperature Range



  • Up to 10°C

  • 10°C to 20°C

  • More than 20°C


By Payload Capacity



  • Up to 10 L

  • 10-20 L

  • 20-40 L

  • 40-150 L

  • More than 150 L


By Type of Use



  • Single use

  • Reusable


By End-Use Industry



  • Pharmaceutical

  • Clinical trial


By Region



  • North America

  • Europe

  • Asia Pacific

  • The Middle East & Africa (MEA)

  • Latin America



Frequently Asked Questions (FAQ) :


The temperature controlled packaging for pharmaceutical market is supposed to register 9.48% CAGR.

The temperature controlled packaging for pharmaceutical market is projected to value at USD 8,762.4 Mn.

The major players are Sonoco ThermoSafe, DB Schenker, Sofrigam, United Parcel Service of America, Inc. (UPS), Softbox Systems Limited, Cold Chain Technologies, Storopack Hans Reichenecker GmbH, KUEHNE + NAGEL INC, Envirotainer AB, DHL International GmbH, Pelican Bio Thermal, and va-Q-tec AG.

The segments of the temperature controlled packaging for pharmaceutical market, by payload capacity, are Up to 10 L, 20-40 L, 10-20 L, 40-150 L, and More than 150 L.

The up to 10 L segment is anticipated to expand at 9.53% CAGR.

The 40-150 L segment is anticipated to mark 9.88% CAGR.

The segments based on end-use industry are pharmaceutical and clinical trial.

The global temperature-controlled packaging for pharmaceutical market is projected to witness a compound annual growth rate of 9.48% during the assessment period (2018-2023). In the pharmaceutical sector, need for effective packaging solutions is more than ever before. Introduction of highly sensitive drugs has necessitated the development of dynamic packaging systems such as temperature-controlled packaging. These packaging systems are purpose-built and have a larger application bandwidth as compared to traditional packaging solutions.


Temperature is one of the most important areas of focus in pharmaceutical packaging, as it can have a severe impact on efficacy of drugs, worse, change their physical nature. To tackle such issues, temperature-controlled packaging solutions are preferred. Such factors are driving the popularity of temperature-controlled packaging in the pharmaceutical sector. The global temperature-controlled packaging for pharmaceutical market has grown at an impressive rate in recent years. Growing investment in R&D and rapid adoption of next-generation cold chain technologies are other factors that are providing an impetus to the market. Also, emphasis is being placed on product innovation and expanding product portfolio. Demand for temperature control packaging solutions that can maintain the required temperature of products even in extreme conditions in on the rise, which is reflecting favorably on the market. In addition, lucrative opportunities in emerging markets across regions such as Asia Pacific, Latin America and Middle East indicate towards an optimistic future for stakeholders.


Segmental Analysis


The segmental analysis of the market is conducted on the basis of product, type, temperature range, payload capacity, type of use, end-use industry, and region.


By product, the market has been segmented as insulated shippers and insulated containers. The insulated shippers segment currently accounts for more than 62% market share. In 2017, the segment stood at a valuation of USD 3,172.3 Mn and is projected to capture a CAGR of 9.26% during the assessment period. This is owing to the rising investment in insulated packaging solution as they offer effective packaging for temperature sensitive products. Insulated shippers are lightweight and versatile in nature.


By type, the market has been segmented into active systems and passive systems. The active systems segment holds the lion’s share of the market. The segment is expected to remain highly attractive over the next couple of years. By the year 2023, the active systems segment is projected to surpass a market valuation of USD 5,000 Mn. Active systems are leased containers with innovative temperature control systems powered by electricity. They are secure, eco-friendly, and facilitate quick loading/ unloading.


By temperature range, the market has been segmented into Up to 10°C, 10°C to 20°C and more than 20°C. The up to 10°C segment accounted for 48.20% share of the market in 2017. The segment is projected to surge at a CAGR of 9.93% during the forecast period. This is owing to increasing usage of packaging solutions with temperature range of up to 10°C in high-risk products such as vaccines, insulins, blood products (such as Factor VIII) and other proteinaceous materials.  


Based on payload capacity, the market has been segmented into up to 10 L, 10-20 L, 20-40 L, 40-150 L, and more than 150 L. The up to 10 L segment currently accounts for the largest market and is expected to remain highly profitable in 2019 and beyond. The segment is expected to reach a market valuation of over USD 2,600 Mn.


Based on type of use, the market has been segmented into single use and reusable. The single-use segment holds the pole position. In 2017, the segment accounted for more than two-third market share.


Based on end-use industry, the market has been segmented into pharmaceutical and clinical trial. The former will continue to outperform the later throughout the assessment period. In 2017, the pharmaceutical segment reached a valuation in excess of USD 4,000 Mn.


Regional Outlook  


The market has been covered across regions such as North America, Latin America, the Middle East & Africa (MEA), Europe and Asia Pacific (APAC). North America is one of the prominent markets for the temperature-controlled packaging for pharmaceutical products. Presence of a favorable investment climate along with the existence of a massive pharmaceutical sector is supporting the growth of the market in the region. Other factors such as stringent pharmaceutical products safety policies and rising geriatric population is creating opportunities for companies operating in the region. North America is followed by Asia-Pacific, and Europe respectively.


Competition Tracking


Cold Chain Technologies, Envirotainer AB, Pelican Bio Thermal, Sofrigam, Softbox Systems Limited, Sonoco ThermoSafe, Storopack Hans Reichenecker GmbH, va-Q-tec AG, DB Schenker, DHL International GmbH, KUEHNE + NAGEL INC, and United Parcel Service of America, Inc. (UPS) are among the leading companies operating in the global temperature-controlled packaging for pharmaceutical market.

1 Executive Summary


2 Market Introduction

2.1 Definition 21

2.2 Scope of the Study 21

2.3 Market Structure 21

2.4 List of Assumptions 22

3 Research Methodology

3.1 Research Process 24

3.2 Primary Research 24

3.3 Secondary Research 25

3.4 Market Size Estimation 26

3.5 Forecast Model 27

4 Market Dynamics

4.1 Introduction 29

4.2 Drivers 29

4.2.1 Growth in the pharmaceutical industry 29

4.2.2 Adoption of smarter cold chain technology 30

4.2.3 Increase in R&D investment in the pharmaceutical industry 30

4.2.4 Drivers Impact Analysis 31

4.3 Restraint 31

4.3.1 Rise in raw material costs 31

4.3.2 Restraint Impact Analysis 32

4.4 Opportunity 32

4.4.1 Balanced clinical trial processes with an authentic data system 32

4.4.2 Government support 32

5 Market Factor Analysis

5.1 Porter’s Five Forces Model 35

5.1.1 Threat of New Entrants 35

5.1.2 Bargaining Power of Suppliers 36

5.1.3 Bargaining Power of Buyers 36

5.1.4 Threat of Substitutes 36

5.1.5 Rivalry 36

5.2 Supply Chain Analysis 36

6 Global Temperature-controlled Packaging for Pharmaceutical Market, by Type

6.1 Overview 39

6.1.1 Active systems 39

6.1.2 Passive systems 39

7 Global Temperature-controlled Packaging for Pharmaceutical Market, by Product

7.1 Overview 42

7.1.1 Insulated Shippers 42

7.1.2 Insulated Containers 42

8 Global Temperature-controlled Packaging for Pharmaceutical Market, by Temperature Range

8.1.1 Up to 10oC 45

8.1.2 10oC to 20oC 45

8.1.3 More than 20oC 45

9 Global Temperature-controlled Packaging for Pharmaceutical Market, by Payload Capacity

9.1 Overview 48

9.1.1 Payload Capacity 48

10 Global Temperature-controlled Packaging for Pharmaceutical Market, by Type of use

10.1 Overview 51

10.1.1 Single Use 51

10.1.2 Re-usable 51

11 Global Temperature-controlled Packaging for Pharmaceutical Market, by End-use Industry

11.1 Overview 54

11.1.1 Pharmaceutical 54

11.1.2 Clinical Trials 54

12 Global Temperature-controlled Packaging for Pharmaceutical Market, by Region

12.1 North America 57

12.1.1 U.S. 59

12.1.2 Canada 61

12.2 Europe 64

12.2.1 Germany 66

12.2.2 U.K 69

12.2.3 France 71

12.2.4 Spain 73

12.2.5 Italy 75

12.2.6 Rest of Europe 77

12.3 Asia-Pacific 80

12.3.1 China 83

12.3.2 Japan 86

12.3.3 South Korea 88

12.3.4 Taiwan 90

12.3.5 Philippines 93

12.3.6 Indonesia 95

12.3.7 Thailand 98

12.3.8 Malaysia 100

12.3.9 Singapore 102

12.3.10 Hong Kong 105

12.3.11 Australia 107

12.3.12 Rest of Asia Pacific 109

12.4 Rest of the World (RoW) 112

12.4.1 Middle East & Africa 114

12.4.2 Latin America 116

13 Competitive Landscape

13.1 Competitive Landscape 120

13.2 Competitors Benchmarking 121

14 Company Profiles

1 Executive Summary 18

2 Market Introduction 20

2.1 Definition 21

2.2 Scope of the Study 21

2.3 Market Structure 21

2.4 List of Assumptions 22

3 Research Methodology 23

3.1 Research Process 24

3.2 Primary Research 24

3.3 Secondary Research 25

3.4 Market Size Estimation 26

3.5 Forecast Model 27

4 Research Methodology 28

4.1 Introduction 29

4.2 Drivers 29

4.2.1 Growth in the pharmaceutical industry 29

4.2.2 Adoption of smarter cold chain technology 30

4.2.3 Increase in R&D investment in the pharmaceutical industry 30

4.2.4 Drivers Impact Analysis 31

4.3 Restraint 31

4.3.1 Rise in raw material costs 31

4.3.2 Restraint Impact Analysis 32

4.4 Opportunity 32

4.4.1 Balanced clinical trial processes with an authentic data system 32

4.4.2 Government support 32

5 Market Factor Analysis 34

5.1 Porter’s Five Forces Model 35

5.1.1 Threat of New Entrants 35

5.1.2 Bargaining Power of Suppliers 36

5.1.3 Bargaining Power of Buyers 36

5.1.4 Threat of Substitutes 36

5.1.5 Rivalry 36

5.2 Supply Chain Analysis 36

6 Global Temperature-controlled Packaging for Pharmaceutical Market, by Type 38

6.1 Overview 39

6.1.1 Active systems 39

6.1.2 Passive systems 39

7 Global Temperature-controlled Packaging for Pharmaceutical Market, by Product 41

7.1 Overview 42

7.1.1 Insulated Shippers 42

7.1.2 Insulated Containers 42

8 Global Temperature-controlled Packaging for Pharmaceutical Market, by Temperature Range 44

8.1 Overview 45

8.1.1 Up to 10oC 45

8.1.2 10oC to 20oC 45

8.1.3 More than 20oC 45

9 Global Temperature-controlled Packaging for Pharmaceutical Market, by Payload Capacity 47

9.1 Overview 48

9.1.1 Payload Capacity 48

10 Global Temperature-controlled Packaging for Pharmaceutical Market, by Type of use 50

10.1 Overview 51

10.1.1 Single Use 51

10.1.2 Re-usable 51

11 Global Temperature-controlled Packaging for Pharmaceutical Market, by End-use Industry 53

11.1 Overview 54

11.1.1 Pharmaceutical 54

11.1.2 Clinical Trials 54

12 Global Temperature-controlled Packaging for Pharmaceutical Market, by Region 56

12.1 North America 57

12.1.1 U.S. 59

12.1.2 Canada 61

12.2 Europe 64

12.2.1 Germany 66

12.2.2 U.K 69

12.2.3 France 71

12.2.4 Spain 73

12.2.5 Italy 75

12.2.6 Rest of Europe 77

12.3 Asia-Pacific 80

12.3.1 China 83

12.3.2 Japan 86

12.3.3 South Korea 88

12.3.4 Taiwan 90

12.3.5 Philippines 93

12.3.6 Indonesia 95

12.3.7 Thailand 98

12.3.8 Malaysia 100

12.3.9 Singapore 102

12.3.10 Hong Kong 105

12.3.11 Australia 107

12.3.12 Rest of Asia Pacific 109

12.4 Rest of the World (RoW) 112

12.4.1 Middle East & Africa 114

12.4.2 Latin America 116

13 Competitive Landscape 119

13.1 Competitive Landscape 120

13.2 Competitors Benchmarking 121

14 Company Profiles 124

14.1 Cold Chain Technologies 125

14.1.1 Company Overview 125

14.1.2 Financial Overview 125

14.1.3 Products/Service Offered 125

14.1.4 Key Developments (2014–2018) 126

14.1.5 SWOT Analysis 126

14.1.6 Key Strategy 126

14.2 Envirotainer AB 127

14.2.1 Company Overview 127

14.2.2 Financial Overview 127

14.2.3 Products/Services Offered 127

14.2.4 Key Developments, (2015-2018) 128

14.2.5 SWOT Analysis 128

14.2.6 Key Strategy 128

14.3 Pelican BioThermal 129

14.3.1 Company Overview 129

14.3.2 Financial Overview 129

14.3.3 Products/Services Offered 129

14.3.4 Key Developments (2015-2018) 138

14.3.5 SWOT Analysis 138

14.3.6 Key Strategy 138

14.4 Sofrigam 139

14.4.1 Company Overview 139

14.4.2 Financial Overview 139

14.4.3 Products/Services Offered 139

14.4.4 Key Developments 141

14.4.5 SWOT Analysis 141

14.4.6 Key Strategy 141

14.5 Softbox Systems Limited 142

14.5.1 Company Overview 142

14.5.2 Financial Overview 142

14.5.3 Products/Service Offered 142

14.5.4 Key Developments 144

14.5.5 SWOT Analysis 145

14.5.6 Key Strategy 145

14.6 Sonoco ThermoSafe 146

14.6.1 Company Overview 146

14.6.2 Financial Overview 146

14.6.3 Products Offered 147

14.6.4 Key Developments (2015-2018) 149

14.6.5 SWOT Analysis 149

14.6.6 Key Strategy 149

14.7 Storopack Hans Reichenecker GmbH 150

14.7.1 Company Overview 150

14.7.2 Financial Overview 150

14.7.3 Products Offered 151

14.7.4 Key Developments (2015-2018) 151

14.7.5 SWOT Analysis 152

14.7.6 Key Strategy 152

14.8 va-Q-tec AG 153

14.8.1 Company Overview 153

14.8.2 Financial Overview 153

14.8.3 Products/Services Offered 154

14.8.4 Key Developments (2015-2018) 156

14.8.5 SWOT Analysis 156

14.8.6 Key Strategy 157

14.9 DB Schenker 158

14.9.1 Company Overview 158

14.9.2 Financial Overview 158

14.9.3 Products/Services Offered 159

14.9.4 Key Developments (2014–2018) 159

14.9.5 SWOT Analysis 160

14.9.6 Key Strategy 160

14.10 DHL International GmbH 161

14.10.1 Company Overview 161

14.10.2 Financial Overview 161

14.10.3 Products/Service Offered 162

14.10.4 Key Developments (2014-2018) 163

14.10.5 SWOT Analysis 163

14.10.6 Key Strategy 163

14.11 KUEHNE + NAGEL INC 164

14.11.1 Company Overview 164

14.11.2 Financial Overview 164

14.11.3 Products/Services Offered 165

14.11.4 Key Developments (2014–2018) 166

14.11.5 SWOT Analysis 166

14.11.6 Key Strategy 166

14.12 United Parcel Service of America, Inc. (UPS) 167

14.12.1 Company Overview 167

14.12.2 Financial Overview 167

14.12.3 Products/Services Offered 168

14.12.4 Key Developments (2014–2018) 169

14.12.5 SWOT Analysis 169

14.12.6 Key Strategy

15 List of Tables

TABLE 1 MARKET SYNOPSIS 19

TABLE 2 LIST OF ASSUMPTIONS 22

TABLE 3 GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE, 2020-2027(USD MILLION) 40

TABLE 4 GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2020-2027(USD MILLION) 43

TABLE 5 INSULATED SHIPPERS: TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICALS MARKET, BY TYPE, 2020-2027(USD MILLION)

43

TABLE 6 GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE, 2020-2027(USD MILLION) 46

TABLE 7 GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY, 2020-2027(USD MILLION) 49

TABLE 8 GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE OF USE, 2020-2027(USD MILLION)

52

TABLE 9 GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END-USE INDUSTRY, 2020-2027(USD MILLION) 55

TABLE 10 NORTH AMERICA: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY COUNTRY, 2020-2027(USD MILLION) 57

TABLE 11 NORTH AMERICA: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2020-2027(USD MILLION) 57

TABLE 12 NORTH AMERICA: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE, 2020-2027(USD MILLION) 57

TABLE 13 NORTH AMERICA: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE, 2020-2027(USD MILLION) 58

TABLE 14 NORTH AMERICA: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY, 2020-2027(USD MILLION) 58

TABLE 15 NORTH AMERICA: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE OF USE, 2020-2027(USD MILLION) 58

TABLE 16 NORTH AMERICA: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END-USE INDUSTRY, 2020-2027(USD MILLION) 59

TABLE 17 U.S.: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2020-2027(USD MILLION)

59

TABLE 18 U.S.: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE, 2020-2027(USD MILLION) 60

TABLE 19 U.S.: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE, 2020-2027(USD MILLION) 60

TABLE 20 U.S.: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY, 2020-2027(USD MILLION) 60

TABLE 21 U.S.: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE OF USE, 2020-2027(USD MILLION) 61

TABLE 22 U.S.: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END-USE INDUSTRY, 2020-2027(USD MILLION) 61

TABLE 23 CANADA: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2020-2027(USD MILLION) 61

TABLE 24 CANADA: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE, 2020-2027(USD MILLION)

62

TABLE 25 CANADA: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE, 2020-2027(USD MILLION) 62


TABLE 26 CANADA: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY, 2020-2027(USD MILLION) 62

TABLE 27 CANADA: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE OF USE, 2020-2027(USD MILLION) 63

TABLE 28 CANADA: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END-USE INDUSTRY, 2020-2027(USD MILLION) 63

TABLE 29 EUROPE: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY COUNTRY, 2020-2027(USD MILLION) 64

TABLE 30 EUROPE: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2020-2027(USD MILLION) 64

TABLE 31 EUROPE: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE, 2020-2027(USD MILLION)

65

TABLE 32 EUROPE: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE, 2020-2027(USD MILLION) 65

TABLE 33 EUROPE: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY, 2020-2027(USD MILLION) 65

TABLE 34 EUROPE: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE OF USE, 2020-2027(USD MILLION) 66

TABLE 35 EUROPE: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END-USE INDUSTRY, 2020-2027(USD MILLION) 66

TABLE 36 GERMANY: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2020-2027(USD MILLION) 66

TABLE 37 GERMANY: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE, 2020-2027(USD MILLION)

67

TABLE 38 GERMANY: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE, 2020-2027 (USD MILLION) 67

TABLE 39 GERMANY: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY, 2020-2027(USD MILLION) 67

TABLE 40 GERMANY: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE OF USE, 2020-2027(USD MILLION) 68

TABLE 41 GERMANY: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END-USE INDUSTRY, 2020-2027(USD MILLION) 68

TABLE 42 UK: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2020-2027(USD MILLION)

69

TABLE 43 UK: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE, 2020-2027(USD MILLION) 69

TABLE 44 UK: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE, 2020-2027(USD MILLION) 69

TABLE 45 UK: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY, 2020-2027(USD MILLION) 70

TABLE 46 UK: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE OF USE, 2020-2027(USD MILLION)

70

TABLE 47 UK: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END-USE INDUSTRY, 2020-2027(USD MILLION) 70

TABLE 48 FRANCE: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2020-2027(USD MILLION) 71

TABLE 49 FRANCE: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE, 2020-2027(USD MILLION)

71

TABLE 50 FRANCE: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE, 2020-2027(USD MILLION) 72

TABLE 51 FRANCE: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY, 2020-2027(USD MILLION) 72

TABLE 52 FRANCE: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE OF USE, 2020-2027(USD MILLION) 72

TABLE 53 FRANCE: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END-USE INDUSTRY, 2020-2027(USD MILLION) 73




TABLE 54 SPAIN: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2020-2027(USD MILLION)

73

TABLE 55 SPAIN: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE, 2020-2027(USD MILLION)

73

TABLE 56 SPAIN: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE, 2020-2027(USD MILLION) 74

TABLE 57 SPAIN: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY, 2020-2027(USD MILLION) 74

TABLE 58 SPAIN: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE OF USE, 2020-2027(USD MILLION) 75

TABLE 59 SPAIN: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END-USE INDUSTRY, 2020-2027(USD MILLION) 75

TABLE 60 ITALY: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2020-2027(USD MILLION)

75

TABLE 61 ITALY: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE, 2020-2027(USD MILLION)76

TABLE 62 ITALY: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE, 2020-2027(USD MILLION) 76

TABLE 63 ITALY: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY, 2020-2027(USD MILLION) 76

TABLE 64 ITALY: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE OF USE, 2020-2027(USD MILLION) 77

TABLE 65 ITALY: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END-USE INDUSTRY, 2020-2027(USD MILLION) 77

TABLE 66 REST OF EUROPE: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2020-2027(USD MILLION) 78

TABLE 67 REST OF EUROPE: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE, 2020-2027(USD MILLION) 78

TABLE 68 REST OF EUROPE: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE, 2020-2027(USD MILLION) 78

TABLE 69 REST OF EUROPE: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY, 2020-2027(USD MILLION) 79

TABLE 70 REST OF EUROPE: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE OF USE, 2020-2027(USD MILLION) 79

TABLE 71 REST OF EUROPE: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END-USE INDUSTRY, 2020-2027(USD MILLION) 79

TABLE 72 ASIA-PACIFIC: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY COUNTRY, 2020-2027(MILLION UNITS) 81

TABLE 73 ASIA-PACIFIC: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2020-2027(USD MILLION) 81

TABLE 74 ASIA-PACIFIC: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE, 2020-2027(USD MILLION) 82

TABLE 75 ASIA-PACIFIC: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE, 2020-2027 (USD MILLION) 82

TABLE 76 ASIA-PACIFIC: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY, 2020-2027 (USD MILLION) 82

TABLE 77 ASIA-PACIFIC: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE OF USE, 2020-2027(USD MILLION) 83

TABLE 78 ASIA-PACIFIC: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END-USE INDUSTRY, 2020-2027 (USD MILLION) 83

TABLE 79 CHINA: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2020-2027(USD MILLION)

84

TABLE 80 CHINA: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE, 2020-2027(USD MILLION)

84

TABLE 81 CHINA: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE, 2020-2027(USD MILLION) 84




TABLE 82 CHINA: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY, 2020-2027(USD MILLION) 85

TABLE 83 CHINA: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE OF USE, 2020-2027(USD MILLION) 85

TABLE 84 CHINA: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END-USE INDUSTRY, 2020-2027(USD MILLION) 85

TABLE 85 JAPAN: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2020-2027(USD MILLION) 86

TABLE 86 JAPAN: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE, 2020-2027(USD MILLION)

86

TABLE 87 JAPAN: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE, 2020-2027(USD MILLION) 87

TABLE 88 JAPAN: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY, 2020-2027(USD MILLION) 87

TABLE 89 JAPAN: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE OF USE, 2020-2027(USD MILLION) 87

TABLE 90 JAPAN: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END-USE INDUSTRY, 2020-2027(USD MILLION) 88

TABLE 91 SOUTH KOREA: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2020-2027(USD MILLION) 88

TABLE 92 SOUTH KOREA: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE, 2020-2027(USD MILLION) 89

TABLE 93 SOUTH KOREA: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE, 2020-2027(USD MILLION) 89

TABLE 94 SOUTH KOREA: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY, 2020-2027 (USD MILLION) 89

TABLE 95 SOUTH KOREA: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE OF USE, 2020-2027(USD MILLION) 90

TABLE 96 SOUTH KOREA: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END-USE INDUSTRY, 2020-2027 (USD MILLION) 90

TABLE 97 TAIWAN: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2020-2027(USD MILLION) 91

TABLE 98 TAIWAN: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE, 2020-2027(USD MILLION)

91

TABLE 99 TAIWAN: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE, 2020-2027(USD MILLION) 91

TABLE 100 TAIWAN: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY, 2020-2027(USD MILLION) 92

TABLE 101 TAIWAN: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE OF USE, 2020-2027(USD MILLION) 92

TABLE 102 TAIWAN: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END-USE INDUSTRY, 2020-2027(USD MILLION) 92

TABLE 103 PHILIPPINES: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2020-2027(USD MILLION) 93

TABLE 104 PHILIPPINES: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE, 2020-2027(USD MILLION) 93

TABLE 105 PHILIPPINES: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE, 2020-2027 (USD MILLION) 94

TABLE 106 PHILIPPINES: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY, 2020-2027 (USD MILLION) 94

TABLE 107 PHILIPPINES: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE OF USE, 2020-2027(USD MILLION) 94

TABLE 108 PHILIPPINES: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END-USE INDUSTRY, 2020-2027 (USD MILLION) 95


TABLE 109 INDONESIA: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2020-2027(USD MILLION) 95

TABLE 110 INDONESIA: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE, 2020-2027(USD MILLION)

96

TABLE 111 INDONESIA: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE, 2020-2027 (USD MILLION) 96

TABLE 112 INDONESIA: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY, 2020-2027(USD MILLION) 96

TABLE 113 INDONESIA: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE OF USE, 2020-2027(USD MILLION) 97

TABLE 114 INDONESIA: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END-USE INDUSTRY, 2020-2027(USD MILLION) 97

TABLE 115 THAILAND: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2020-2027(USD MILLION) 98

TABLE 116 THAILAND: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE, 2020-2027(USD MILLION)

98

TABLE 117 THAILAND: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE, 2020-2027 (USD MILLION) 99

TABLE 118 THAILAND: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY, 2020-2027(USD MILLION) 99

TABLE 119 THAILAND: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE OF USE, 2020-2027(USD MILLION) 99

TABLE 120 THAILAND: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END-USE INDUSTRY, 2020-2027(USD MILLION) 100

TABLE 121 MALAYSIA: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2020-2027(USD MILLION) 100

TABLE 122 MALAYSIA: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE, 2020-2027(USD MILLION)

101

TABLE 123 MALAYSIA: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE, 2020-2027 (USD MILLION) 101

TABLE 124 MALAYSIA: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY, 2020-2027(USD MILLION) 101

TABLE 125 MALAYSIA: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE OF USE, 2020-2027(USD MILLION) 102

TABLE 126 MALAYSIA: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END-USE INDUSTRY, 2020-2027(USD MILLION) 102

TABLE 127 SINGAPORE: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2020-2027(USD MILLION) 103

TABLE 128 SINGAPORE: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE, 2020-2027(USD MILLION) 103

TABLE 129 SINGAPORE: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE, 2020-2027 (USD MILLION) 103

TABLE 130 SINGAPORE: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY, 2020-2027 (USD MILLION) 104

TABLE 131 SINGAPORE: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE OF USE, 2020-2027(USD MILLION) 104

TABLE 132 SINGAPORE: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END-USE INDUSTRY, 2020-2027 (USD MILLION) 104

TABLE 133 HONG KONG: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2020-2027(USD MILLION) 105

TABLE 134 HONG KONG: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE, 2020-2027(USD MILLION) 105

TABLE 135 HONG KONG: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE, 2020-2027 (USD MILLION) 105


TABLE 136 HONG KONG: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY, 2020-2027 (USD MILLION) 106

TABLE 137 HONG KONG: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE OF USE, 2020-2027(USD MILLION) 106

TABLE 138 HONG KONG: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END-USE INDUSTRY, 2020-2027 (USD MILLION) 106

TABLE 139 AUSTRALIA: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2020-2027(USD MILLION) 107

TABLE 140 AUSTRALIA: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE, 2020-2027(USD MILLION) 107

TABLE 141 AUSTRALIA: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE, 2020-2027 (USD MILLION) 108

TABLE 142 AUSTRALIA: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY, 2020-2027 (USD MILLION) 108

TABLE 143 AUSTRALIA: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE OF USE, 2020-2027(USD MILLION) 108

TABLE 144 AUSTRALIA: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END-USE INDUSTRY, 2020-2027(USD MILLION) 109

TABLE 145 REST OF ASIA PACIFIC: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 109

TABLE 146 REST OF ASIA PACIFIC: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE, 2020-2027(USD MILLION) 109

TABLE 147 REST OF ASIA PACIFIC: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE, 2020-2027(USD MILLION) 110

TABLE 148 REST OF ASIA PACIFIC: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY, 2020-2027(USD MILLION) 110

TABLE 149 REST OF ASIA PACIFIC: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE OF USE, 2020-2027 (USD MILLION) 111

TABLE 150 REST OF ASIA PACIFIC: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END-USE INDUSTRY, 2020-2027(USD MILLION) 111

TABLE 151 MIDDLE EAST & AFRICA: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY REGION, 2020-2027(USD MILLION) 112

TABLE 152 REST OF THE WORLD (ROW): GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2020-2027(USD MILLION) 112

TABLE 153 REST OF THE WORLD (ROW): GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE, 2020-2027 (USD MILLION) 112

TABLE 154 REST OF THE WORLD (ROW): GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE, 2020-2027(USD MILLION) 113

TABLE 155 REST OF THE WORLD (ROW): GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY, 2020-2027(USD MILLION) 113

TABLE 156 REST OF THE WORLD (ROW): GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE OF USE, 2020-2027(USD MILLION) 113

TABLE 157 REST OF THE WORLD (ROW): GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END-USE INDUSTRY, 2020-2027(USD MILLION) 114

TABLE 158 MIDDLE EAST & AFRICA: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 114

TABLE 159 MIDDLE EAST & AFRICA: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE, 2020-2027(USD MILLION) 115

TABLE 160 MIDDLE EAST & AFRICA: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE, 2020-2027(USD MILLION) 115

TABLE 161 MIDDLE EAST & AFRICA: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY, 2020-2027(USD MILLION) 115

TABLE 162 MIDDLE EAST & AFRICA: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE OF USE, 2020-2027 (USD MILLION) 116


TABLE 163 MIDDLE EAST & AFRICA: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END-USE INDUSTRY, 2020-2027(USD MILLION) 116

TABLE 164 LATIN AMERICA: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2020-2027(USD MILLION) 116

TABLE 165 LATIN AMERICA: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE, 2020-2027(USD MILLION) 117

TABLE 166 LATIN AMERICA: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE, 2020-2027(USD MILLION) 117

TABLE 167 LATIN AMERICA: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY, 2020-2027 (USD MILLION) 117

TABLE 168 LATIN AMERICA: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE OF USE, 2020-2027(USD MILLION) 118

TABLE 169 LATIN AMERICA: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END-USE INDUSTRY, 2020-2027 (USD MILLION) 118

TABLE 170 GLOBAL DASHBOARD - PACKAGING COMPANIES 121

TABLE 171 ASIA-PACIFIC DASHBOARD - PACKAGING COMPANIES 122

TABLE 172 GLOBAL DASHBOARD - LOGISTICS COMPANIES 123

TABLE 173 ASIA-PACIFIC DASHBOARD - LOGISTICS COMPANIES

16 List of Figures

FIGURE 1 GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET: MARKET STRUCTURE 21

FIGURE 2 RESEARCH PROCESS OF MRFR 24

FIGURE 3 TOP DOWN & BOTTOM UP APPROACH 27

FIGURE 4 DRO ANALYSIS OF GLOBAL TEMERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET 29

FIGURE 5 GLOBAL PHARMACEUTICAL SPENDING, 2005-2015 30

FIGURE 6 DRIVERS IMPACT ANALYSIS 31

FIGURE 7 POLYSTYRENE PRICE, 2013-2018, (USD/KG) 31

FIGURE 8 RESTRAINT IMPACT ANALYSIS 32

FIGURE 9 PORTER'S FIVE FORCES ANALYSIS OF THE GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET 35

FIGURE 10 SUPPLY CHAIN ANALYSIS 36

FIGURE 11 GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET SHARE, BY TYPE, 2020 (%) 39

FIGURE 12 GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET SHARE, BY PRODUCT, 2020 (%) 42

FIGURE 13 GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET SHARE, BY TEMPERATURE RANGE, 2020 (%)

45

FIGURE 14 GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET SHARE, BY PAYLOAD CAPACITY, 2020 (%) 48 FIGURE 15 GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET SHARE, BY TYPE OF USE, 2020 (%) 51

FIGURE 16 GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET SHARE, BY END-USE INDUSTRY, 2020 (%) 54

FIGURE 17 ASIA-PACIFIC: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY COUNTRY, 2020-2027(USD

MILLION) 80

FIGURE 18 BENCHMARKING OF MAJOR COMPETITORS - PACKAGING COMPANIES 121

FIGURE 19 BENCHMARKING OF MAJOR COMPETITORS - LOGISTICS COMPANIES 123

FIGURE 20 COLD CHIN TECHNOLOGIES: SWOT ANALYSIS 126

FIGURE 21 ENVIROTAINER AB: SWOT ANALYSIS 128

FIGURE 22 PELICAN BIOTHERMAL: SWOT ANALYSIS 138

FIGURE 23 SOFRIGAM: SWOT ANALYSIS 141

FIGURE 24 SOFTBOX: SWOT ANALYSIS 145

FIGURE 25 SONOCO: TOTAL REVENUE VS SEGMENTAL REVENUE, 2020-2027 (USD MILLION) 146

FIGURE 26 SONOCO: REGIONAL REVENUE, 2020 (USD MILLION) 147

FIGURE 27 SONOCO: SWOT ANALYSIS 149

FIGURE 28 STOROPACK HANS REICHENECKER GMBH: TOTAL REVENUE, 2020-2027 (USD MILLION) 150

FIGURE 29 STOROPACK HANS REICHENECKER GMBH: REGIONAL REVENUE, 2016 (USD MILLION) 151

FIGURE 30 STOROPACK HANS REICHENECKER GMBH: SWOT ANALYSIS 152

FIGURE 31 VA-Q-TEC AG: TOTAL REVENUE, 2020-2027 (USD MILLION) 153

FIGURE 32 VA-Q-TEC AG: REGIONAL REVENUE, 2020 (USD MILLION) 154

FIGURE 33 VA-Q-TEC AG: SWOT ANALYSIS 156

FIGURE 34 DEUTSCHE BAHN AG: TOTAL REVENUE, 2020-2027 (USD MILLION) 158

FIGURE 35 DEUTSCHE BAHN AG: REGIONAL REVENUE, 2020 (%) 159

FIGURE 36 DB SCHENKER: SWOT ANALYSIS 160

FIGURE 37 DHL INTERNATIONAL GMBH: TOTAL REVENUE, 2020-2027 (USD MILLION) 161

FIGURE 38 DHL INTERNATIONAL GMBH: SEGMENTAL REVENUE, 2020 (%) 162

FIGURE 39 DHL INTERNATIONAL GMBH: REGIONAL REVENUE, 2020 (%) 162

FIGURE 40 DHL INTERNATIONAL GMBH: SWOT ANALYSIS 163

FIGURE 41 KUEHNE + NAGEL INC: TOTAL REVENUE, 2020-2027 (USD MILLION) 164

FIGURE 42 KUEHNE + NAGEL INC: SEGMENTAL REVENUE, 2020 (%) 165

FIGURE 43 KUEHNE + NAGEL INC: REGIONAL REVENUE, 2020 (%) 165

FIGURE 44 KUEHNE + NAGEL INC: SWOT ANALYSIS 166

FIGURE 45 UNITED PARCEL SERVICE OF AMERICA, INC.: TOTAL REVENUE, 2020-2027 (USD MILLION) 167

FIGURE 46 UNITED PARCEL SERVICE OF AMERICA, INC.: SEGMENTAL REVENUE, 2020 (%) 168

FIGURE 47 UNITED PARCEL SERVICE OF AMERICA, INC.: REGIONAL REVENUE, 2020 (%) 168

FIGURE 48 UNITED PARCEL SERVICE OF AMERICA, INC.: SWOT ANALYSIS 169

Global Temperature-controlled Packaging for Pharmaceutical Market- Competitive Landscape


Market Research Future includes following key players for global Temperature-controlled Packaging for Pharmaceutical Market research study: Envirotainer AB, Pelican Biothermal LLC, Sofrigam, Softbox Systems Limited, Sonoco ThermoSafe, Storopack Hans Reichenecker GmbH, and Va-Q-Tec AG and the major logistic companies are DHL International GmbH, Yusen Logistics, Agility, CEVA logistics, DB Schenker, DHL International GmbH, and KUEHNE + NAGEL INC.


The market share analysis is derived by considering various factors such as financial position, segmental R&D investment, product innovations, corporate strength, product portfolio, strategy analysis, and, key innovations in the market among other factors. The major players holding prominent position in the Market are Sonoco ThermoSafe, Storopack Hans Reichenecker GmbH, Envirotainer AB, Cold Chain Technologies, and Softbox Systems Ltd. among others.


According to MRFR analysis, Sonoco ThermoSafe is a global giant in temperature assurance packaging for efficient and safe transportation of pharmaceuticals, vaccines, and other temperature sensitive products with 5.2% market share. The company has broad portfolio for other products such as insulated slippers, durable insulated containers, protective packaging and diagnostic. The company has 30 global location (15 ThermoSafe dedicated and 15 Sonoco Protective solution), out of which more than 50 plant sites are in Southeast Asia and 8 sites are in China. The company believes that cash generated from operations will help focus on the development of new products, and new markets, as well as it will help gain customers.


Storopack Hans Reichenecker GmbH is the second largest company offering nnovative and effective packaging solutions with 3.8% of the total market share. The company has a wide line of offerings, which include flexible protective packaging, temperature controlled protective packaging, customized protective packaging, technical molded parts, which are applicable in automotive, consumer electronics, industry, food, and pharmaceutical industries. It is continuously working on the challenges encountered while offering appropriate solutions and the highest level of services for changing demands of customers.


Envirotainer AB holds the third largest market share of the market with 2.5%. The company develops and manufactures innovative containers, including validation and testing, services for pharmaceutical products, which require for temperature controlled packaging. It offers services such as the active cold chain containers, and cold chain services which include various subsegments such as technical support, post-shipment analysis, qualification services, shipment set up services, and active cold chain membership. The company focuses on forming partnerships and increasing the number of warehouses based on demand and sales in various regions to gain the maximum number of customers.


Cold Chain Technologies (CCT) holds the fourth largest market share with 0.7% of the global market. It offers a wide range of cost-effective packaging options for Just in Time (JIT) delivery to the customers. The company includes, standard and custom KoolTemp qualified shipping systems and containers, Koolit refrigerants and PCMs and temperature indicators and loggers. It’s extensive thermal packaging design and manufacturing experience enables it to provide quality focused products and services to clients around the world in markets that include pharmaceutical and biotech manufacturers, third-party logistic (3PL) providers, and specialty pharmacies.


Softbox Systems Ltd. holds 0.4% of the global market share. The company is involved in the design, development, and production of passive temperature-controlled packaging systems for pharmaceutical companies. Recently, company has made a number of acquisitions of major companies such as Cold Tech Systems, TP3 Global, and Tempack. This will strengthen its portfolio in the future.